OnQ Research is a full service South African contract research organisation. Based in Johannesburg, South Africa, OnQ Research is able to offer services to assist with the entire continuum of clinical research. OnQ partners with its clients from protocol and programme design and development through to study start-up, project management, monitoring, data management, and clinical report generation.
Contract research experience in clinical research areas
OnQ Research has experience in the following areas of clinical research:
- Bioequivalence
- Phase I–IV
- Academic research
- Registries
- Post marketing / surveillance studies
- Cosmetic studies
- Complementary medicine studies
- Traditional medicine studies
- Device studies
- Health economic market assessment
OnQ Research has been involved in over 100 clinical studies, in varied types of therapeutic areas, for over ten years. OnQ Research was established in 1999, and has evolved into one of the premier African contract research organisations.
International clinical trial project management experience
OnQ Research prides itself on its in-house expertise and, with this expertise on board, is able to partner with its clients to facilitate trials in other geographical regions should this be required. Our staff includes medical doctors as well as project managers with international clinical trial project management experience.
OnQ Research is able to assist clients with supplementary requirements such as import licence, registrations of product, facilitation of vendors such as laboratories, and investigational product management and labelling.
Clinical trials in South Africa
South Africa as a location within which to conduct clinical trials has all the benefits of first-world locations, such as world-renowned specialists and physicians, top-class hospital and clinic facilities, and an inordinate array of experienced clinical research professionals.
South Africa has sophisticated and reputable regulatory and ethics authorities. All clinical research professionals are required to undergo formal GCP training at least every three years.
Varied patient populations and therapeutic areas for clinical trials
Coupled with this, South Africa is considered an emerging market region, and consequently has a cost benefit, as well as an availability of varied patient populations and therapeutic areas. Typically, South Africa features prominently in achieving or exceeding patient targets within the required time-frame.
Development of skilled clinical research sites throughout Africa
South Africa cannot be considered in isolation, without the opportunity to include other African countries. OnQ Research has extensive experience in conducting research in various African countries; e.g. Mozambique, Botswana, Rwanda, Ghana, Uganda, Kenya and Tanzania. This includes evaluating a new area and facilitating the development of fully-fledged, skilled clinical research sites through site assessment and capacity and resource building.